Literature DB >> 35462481

[Guidelines on the diagnosis and management of primary biliary cholangitis (2021)].

.   

Abstract

In 2015, the Chinese Society of Hepatology and Chinese Society of Gastroenterology issued a consensus on the diagnosis and management of primary biliary cholangitis (PBC). In the past years, more clinical studies have been reported in the field of PBC. To provide guidance to the clinical diagnosis and management of patients with PBC, the Chinese Society of Hepatology invited a panel of experts to assess the new clinical evidence and formulated the current guidelines which comprises 26 clinical recommendations.

Entities:  

Mesh:

Year:  2022        PMID: 35462481     DOI: 10.3760/cma.j.cn112138-20211112-00794-1

Source DB:  PubMed          Journal:  Zhonghua Gan Zang Bing Za Zhi        ISSN: 1007-3418


  2 in total

1.  Efficacy and safety of fenofibrate add-on therapy in patients with primary biliary cholangitis refractory to ursodeoxycholic acid: A retrospective study and updated meta-analysis.

Authors:  Xuan Guoyun; Ding Dawei; Liu Ning; Hu Yinan; Yang Fangfang; Tian Siyuan; Sun Hao; Yang Jiaqi; Xu Ang; Guo Guanya; Chen Xi; Shang Yulong; Han Ying
Journal:  Front Pharmacol       Date:  2022-08-30       Impact factor: 5.988

2.  Disease predisposition of human leukocyte antigen class II genes influences the gut microbiota composition in patients with primary biliary cholangitis.

Authors:  Chun-Yang Huang; Hai-Ping Zhang; Wei-Jia Han; Dan-Tong Zhao; Hui-Yu Liao; Yin-Xue Ma; Bin Xu; Li-Juan Li; Ying Han; Xiu-Hong Liu; Qi Wang; Jin-Li Lou; Xiao-Dan Zhang; Juan Zhao; Wen-Juan Li; Yan-Min Liu; Hui-Ping Yan
Journal:  Front Immunol       Date:  2022-09-20       Impact factor: 8.786

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.